News
Hesperos creates first organ-on-a-chip digital twin to predict drug responses, setting a new benchmark for New Approach ...
Certara today announced the launch of its industry-leading Phoenix 8.0 PK/PD modeling and simulation software for drug development scientists.
Antibe Receives Approval to Initiate PK/PD Study of Otenaproxesul. Antibe Receives Approval to Initiate PK/PD Study of Otenaproxesul. September 28, 2023 07:00 AM Eastern Daylight Time.
More on the ENTX & OPK’s Collaborative PK/PD Research Results. OXM is a naturally occurring peptide hormone found in the colon, with GLP-1 and glucagon dual agonist activity, ...
BMS-986504 demonstrated a favorable PK/PD profile, supporting QD dosing at 400 and 600 mg. These results support further investigation of BMS-986504 at 400 and 600 mg QD as a potential first-in-class ...
Findings from a phase 3 trial showed denosumab-dssb had comparable efficacy, safety, immunogenicity, PK and PD to Prolia in patients with postmenopausal osteoporosis. Ospomyv is approved to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results